Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

NKG2A inhibits NKG2C effector functions of γδ T cells: implications in health and disease.

Angelini DF, Zambello R, Galandrini R, Diamantini A, Placido R, Micucci F, Poccia F, Semenzato G, Borsellino G, Santoni A, Battistini L.

J Leukoc Biol. 2011 Jan;89(1):75-84. doi: 10.1189/jlb.0710413. Epub 2010 Oct 15.

PMID:
20952657
2.

Thiopyrophosphoantigens: solid-phase synthesis and in vitro characterization of a new class of Vgamma9 Vdelta2 T cells activators.

Breccia P, Angeli F, Cerbara I, Topai A, Auricchio G, Martino A, Colizzi V, Poccia F.

J Med Chem. 2009 Jun 25;52(12):3716-22. doi: 10.1021/jm900054u.

PMID:
19453173
3.

Zoledronic acid and interleukin-2 treatment improves immunocompetence in HIV-infected persons by activating Vgamma9Vdelta2 T cells.

Poccia F, Gioia C, Martini F, Sacchi A, Piacentini P, Tempestilli M, Agrati C, Amendola A, Abdeddaim A, Vlassi C, Malkovsky M, D'Offizi G.

AIDS. 2009 Mar 13;23(5):555-65. doi: 10.1097/QAD.0b013e3283244619.

PMID:
19238075
4.

In vivo effects of zoledronic acid on peripheral gammadelta T lymphocytes in early breast cancer patients.

Santini D, Martini F, Fratto ME, Galluzzo S, Vincenzi B, Agrati C, Turchi F, Piacentini P, Rocci L, Manavalan JS, Tonini G, Poccia F.

Cancer Immunol Immunother. 2009 Jan;58(1):31-8. doi: 10.1007/s00262-008-0521-6. Epub 2008 May 6.

PMID:
18458903
5.

Activation of interferon response genes and of plasmacytoid dendritic cells in HIV-1 positive subjects with GB virus C co-infection.

Lalle E, Sacchi A, Abbate I, Vitale A, Martini F, D'Offizi G, Antonucci G, Castilletti C, Poccia F, Capobianchi MR.

Int J Immunopathol Pharmacol. 2008 Jan-Mar;21(1):161-71.

PMID:
18336742
6.

Cross-subtype immunity against avian influenza in persons recently vaccinated for influenza.

Gioia C, Castilletti C, Tempestilli M, Piacentini P, Bordi L, Chiappini R, Agrati C, Squarcione S, Ippolito G, Puro V, Capobianchi MR, Poccia F.

Emerg Infect Dis. 2008 Jan;14(1):121-8. doi: 10.3201/eid1401.061283.

7.

T cell selection and differentiation in AIDS disease: the model of HIV-discordant monozygotic twins.

Agrati C, Gioia C, Soldani F, Martini F, Antinori A, Poccia F.

J Biol Regul Homeost Agents. 2006 Jan-Jun;20(1-2):24-8.

PMID:
18088551
8.

Gamma delta T cells and dendritic cells: close partners and biological adjuvants for new therapies.

Martino A, Poccia F.

Curr Mol Med. 2007 Nov;7(7):658-73. Review.

PMID:
18045144
9.

An IL-15 dependent CD8 T cell response to selected HIV epitopes is related to viral control in early-treated HIV-infected subjects.

D'Offizi G, Gioia C, Corpolongo A, Martini F, Paganelli R, Volpi I, Sacchi A, Tozzi V, Narciso P, Poccia F.

Int J Immunopathol Pharmacol. 2007 Jul-Sep;20(3):473-85.

PMID:
17880761
11.

Differential expression of Werner and Bloom syndrome genes in the peripheral blood of HIV-1 infected patients.

Bordi L, Gioia C, Lalle E, Piselli P, Poccia F, Capobianchi MR, Amendola A.

Hum Immunol. 2007 Feb;68(2):91-9. Epub 2006 Dec 22.

PMID:
17321898
12.

Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study.

Goletti D, Parracino MP, Butera O, Bizzoni F, Casetti R, Dainotto D, Anzidei G, Nisii C, Ippolito G, Poccia F, Girardi E.

Respir Res. 2007 Jan 27;8:5.

13.

A tuberculosis vaccine based on phosphoantigens and fusion proteins induces distinct gammadelta and alphabeta T cell responses in primates.

Cendron D, Ingoure S, Martino A, Casetti R, Horand F, Romagné F, Sicard H, Fournié JJ, Poccia F.

Eur J Immunol. 2007 Feb;37(2):549-65.

14.

Sphingosine 1-phosphate interferes on the differentiation of human monocytes into competent dendritic cells.

Martino A, Volpe E, Auricchio G, Izzi V, Poccia F, Mariani F, Colizzi V, Baldini PM.

Scand J Immunol. 2007 Jan;65(1):84-91.

15.

Enhancement of BCG-induced Th1 immune response through Vgamma9Vdelta2 T cell activation with non-peptidic drugs.

Martino A, Casetti R, Poccia F.

Vaccine. 2007 Jan 22;25(6):1023-9. Epub 2006 Oct 9.

PMID:
17118497
16.

CXCR5 identifies a subset of Vgamma9Vdelta2 T cells which secrete IL-4 and IL-10 and help B cells for antibody production.

Caccamo N, Battistini L, Bonneville M, Poccia F, Fournié JJ, Meraviglia S, Borsellino G, Kroczek RA, La Mendola C, Scotet E, Dieli F, Salerno A.

J Immunol. 2006 Oct 15;177(8):5290-5.

17.

Region of difference 1 antigen-specific CD4+ memory T cells correlate with a favorable outcome of tuberculosis.

Goletti D, Butera O, Bizzoni F, Casetti R, Girardi E, Poccia F.

J Infect Dis. 2006 Oct 1;194(7):984-92. Epub 2006 Aug 30.

PMID:
16960787
18.

Influence of GBV-C infection on the endogenous activation of the IFN system in HIV-1 co-infected patients.

Capobianchi MR, Lalle E, Martini F, Poccia F, D'Offizi G, Antonucci G, Abbate I, Dianzani F.

Cell Mol Biol (Noisy-le-grand). 2006 May 15;52(1):3-8.

PMID:
16914092
19.

Interferon-gamma-mediated antiviral immunity against orthopoxvirus infection is provided by gamma delta T cells.

Agrati C, Castilletti C, De Santis R, Cimini E, Bordi L, Malkovsky M, Poccia F, Capobianchi MR.

J Infect Dis. 2006 Jun 1;193(11):1606-7; author reply 1607-8. No abstract available.

PMID:
16652291
20.

CD8 T cell response to Nef peptides and HIV type 1 control in early-treated patients after antiretroviral treatment interruption.

Poccia F, Gioia C, Corpolongo A, D'Offizi G, Narcisco P, Martini F.

AIDS Res Hum Retroviruses. 2006 Apr;22(4):330-2. No abstract available.

PMID:
16623635
21.

Anti-severe acute respiratory syndrome coronavirus immune responses: the role played by V gamma 9V delta 2 T cells.

Poccia F, Agrati C, Castilletti C, Bordi L, Gioia C, Horejsh D, Ippolito G, Chan PK, Hui DS, Sung JJ, Capobianchi MR, Malkovsky M.

J Infect Dis. 2006 May 1;193(9):1244-9. Epub 2006 Mar 27. Erratum in: J Infect Dis. 2006 Jul 15;194(2):267.

PMID:
16586361
22.

Accumulation of dysfunctional effector CD8+ T cells in the liver of patients with chronic HCV infection.

Nisii C, Tempestilli M, Agrati C, Poccia F, Tocci G, Longo MA, D'Offizi G, Tersigni R, Lo Iacono O, Antonucci G, Oliva A.

J Hepatol. 2006 Mar;44(3):475-83. Epub 2005 Dec 5.

PMID:
16426698
23.

Activation of Vgamma9Vdelta2 T cells by non-peptidic antigens induces the inhibition of subgenomic HCV replication.

Agrati C, Alonzi T, De Santis R, Castilletti C, Abbate I, Capobianchi MR, D'Offizi G, Siepi F, Fimia GM, Tripodi M, Poccia F.

Int Immunol. 2006 Jan;18(1):11-8. Epub 2005 Dec 16.

PMID:
16361319
24.

Gamma delta T cells and resolution of cytomegalovirus infection in an HIV/HCV coinfected patient after liver transplantation.

D'Offizi G, Gioia C, Martini F, Volpi I, Solmone M, Poccia F, Narciso P, Vennarecci G, Ettore GM, Antonini M, Santoro E, Carosi G.

Transplantation. 2005 Nov 27;80(10):1523-4. No abstract available.

PMID:
16340802
25.

CD1d expression by hepatocytes is a main restriction element for intrahepatic T-cell recognition.

Agrati C, Martini F, Nisii C, Oliva A, D'Offizi G, Narciso P, Nardacci R, Piacentini M, Dieli F, Pucillo LP, Poccia F.

J Biol Regul Homeost Agents. 2005 Jan-Jun;19(1-2):41-8.

PMID:
16178273
26.

T-Cell response profiling to biological threat agents including the SARS coronavirus.

Gioia C, Horejsh D, Agrati C, Martini F, Capobianchi MR, Ippolito G, Poccia F.

Int J Immunopathol Pharmacol. 2005 Jul-Sep;18(3):525-30.

PMID:
16164833
27.

Vgamma9Vdelta2 T cell-mediated non-cytolytic antiviral mechanisms and their potential for cell-based therapy.

Poccia F, Agrati C, Martini F, Mejia G, Wallace M, Malkovsky M.

Immunol Lett. 2005 Aug 15;100(1):14-20. Review.

PMID:
16115692
28.

Coordinate induction of IFN-alpha and -gamma by SARS-CoV also in the absence of virus replication.

Castilletti C, Bordi L, Lalle E, Rozera G, Poccia F, Agrati C, Abbate I, Capobianchi MR.

Virology. 2005 Oct 10;341(1):163-9.

29.

Is there an answer? Is there a genetic basis for human susceptibility to leprosy?

Fabozzi G, Modiano G, Poccia F, Visca P, Ascenzi P.

IUBMB Life. 2005 Feb;57(2):119-21. No abstract available.

30.

Drug-induced expansion and differentiation of V gamma 9V delta 2 T cells in vivo: the role of exogenous IL-2.

Casetti R, Perretta G, Taglioni A, Mattei M, Colizzi V, Dieli F, D'Offizi G, Malkovsky M, Poccia F.

J Immunol. 2005 Aug 1;175(3):1593-8.

31.

Complementary function of gamma delta T-lymphocytes and dendritic cells in the response to isopentenyl-pyrophosphate and lipopolysaccharide antigens.

Martino A, Casetti R, D'Alessandri A, Sacchi A, Poccia F.

J Clin Immunol. 2005 May;25(3):230-7.

PMID:
15981088
32.

Close encounters of different kinds: dendritic cells and gamma delta T cells heighten therapeutic applications.

Martino A, Poccia F.

Immunol Lett. 2005 Oct 15;101(1):115. No abstract available.

PMID:
15941592
33.

Differential requirements for antigen or homeostatic cytokines for proliferation and differentiation of human Vgamma9Vdelta2 naive, memory and effector T cell subsets.

Caccamo N, Meraviglia S, Ferlazzo V, Angelini D, Borsellino G, Poccia F, Battistini L, Dieli F, Salerno A.

Eur J Immunol. 2005 Jun;35(6):1764-72.

34.

HLA-E up-regulation induced by HIV infection may directly contribute to CD94-mediated impairment of NK cells.

Martini F, Agrati C, D'Offizi G, Poccia F.

Int J Immunopathol Pharmacol. 2005 Apr-Jun;18(2):269-76.

PMID:
15888249
35.

Antiviral reactivities of gammadelta T cells.

Poccia F, Agrati C, Martini F, Capobianchi MR, Wallace M, Malkovsky M.

Microbes Infect. 2005 Mar;7(3):518-28. Epub 2005 Mar 3. Review.

PMID:
15777667
36.

Skewed representation of functionally distinct populations of Vgamma9Vdelta2 T lymphocytes in aging.

Re F, Poccia F, Donnini A, Bartozzi B, Bernardini G, Provinciali M.

Exp Gerontol. 2005 Jan-Feb;40(1-2):59-66.

PMID:
15664733
37.

A molecular beacon, bead-based assay for the detection of nucleic acids by flow cytometry.

Horejsh D, Martini F, Poccia F, Ippolito G, Di Caro A, Capobianchi MR.

Nucleic Acids Res. 2005 Jan 19;33(2):e13.

38.

Influence of GB virus type C and HIV coinfection on gamma delta T cells.

Martini F, Solmone M, Agrati C, Capobianchi MR, Iacomi F, Antonucci G, Poccia F.

Clin Infect Dis. 2005 Jan 15;40(2):326-8; author reply 328-9. No abstract available.

PMID:
15655761
39.

Mutation, fitness, viral diversity, and predictive markers of disease progression in a computational model of HIV type 1 infection.

Castiglione F, Poccia F, D'Offizi G, Bernaschi M.

AIDS Res Hum Retroviruses. 2004 Dec;20(12):1314-23.

PMID:
15650424
40.

Reciprocal activating interaction between dendritic cells and pamidronate-stimulated gammadelta T cells: role of CD86 and inflammatory cytokines.

Conti L, Casetti R, Cardone M, Varano B, Martino A, Belardelli F, Poccia F, Gessani S.

J Immunol. 2005 Jan 1;174(1):252-60.

41.

Murine hepatocyte cell lines promote expansion and differentiation of NK cells from stem cell precursors.

Bordoni V, Alonzi T, Agrati C, Poccia F, Borsellino G, Mancino G, Fimia GM, Piacentini M, Fantoni A, Tripodi M.

Hepatology. 2004 Jun;39(6):1508-16.

PMID:
15185291
42.

FcgammaRIII discriminates between 2 subsets of Vgamma9Vdelta2 effector cells with different responses and activation pathways.

Angelini DF, Borsellino G, Poupot M, Diamantini A, Poupot R, Bernardi G, Poccia F, Fournié JJ, Battistini L.

Blood. 2004 Sep 15;104(6):1801-7. Epub 2004 Jun 3.

43.

Steatosis and intrahepatic lymphocyte recruitment in hepatitis C virus transgenic mice.

Alonzi T, Agrati C, Costabile B, Cicchini C, Amicone L, Cavallari C, Rocca CD, Folgori A, Fipaldini C, Poccia F, Monica NL, Tripodi M.

J Gen Virol. 2004 Jun;85(Pt 6):1509-20.

PMID:
15166435
44.

Highly active antiretroviral therapy restores CD4+ Vbeta T-cell repertoire in patients with primary acute HIV infection but not in treatment-naive HIV+ patients with severe chronic infection.

Cossarizza A, Poccia F, Agrati C, D'Offizi G, Bugarini R, Pinti M, Borghi V, Mussini C, Esposito R, Ippolito G, Narciso P.

J Acquir Immune Defic Syndr. 2004 Mar 1;35(3):213-22.

PMID:
15076235
45.

Flow cytometry and T-cell response monitoring after smallpox vaccination.

Poccia F, Gioia C, Montesano C, Martini F, Horejsh D, Castilletti C, Pucillo Lp, Capobianchi MR, Ippolito G.

Emerg Infect Dis. 2003 Nov;9(11):1468-70.

46.

Different cytokine production and effector/memory dynamics of alpha beta+ or gamma delta+ T-cell subsets in the peripheral blood of patients with active pulmonary tuberculosis.

Gioia C, Agrati C, Goletti D, Vincenti D, Carrara S, Amicosante M, Casarini M, Giosue S, Puglisi G, Rossi A, Colizzi V, Pucillo LP, Poccia F.

Int J Immunopathol Pharmacol. 2003 Sep-Dec;16(3):247-52.

PMID:
14611728
47.

Induction of gammadelta T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo.

Dieli F, Gebbia N, Poccia F, Caccamo N, Montesano C, Fulfaro F, Arcara C, Valerio MR, Meraviglia S, Di Sano C, Sireci G, Salerno A.

Blood. 2003 Sep 15;102(6):2310-1. No abstract available.

48.

Levels of interleukin-15 in plasma may predict a favorable outcome of structured treatment interruption in patients with chronic human immunodeficiency virus infection.

Amicosante M, Poccia F, Gioia C, Montesano C, Topino S, Martini F, Narciso P, Pucillo LP, D'Offizi G.

J Infect Dis. 2003 Sep 1;188(5):661-5. Epub 2003 Aug 18.

PMID:
12934181
49.

Differentiation of effector/memory Vdelta2 T cells and migratory routes in lymph nodes or inflammatory sites.

Dieli F, Poccia F, Lipp M, Sireci G, Caccamo N, Di Sano C, Salerno A.

J Exp Med. 2003 Aug 4;198(3):391-7.

50.

V gamma 9V delta 2 T-cell anergy and complementarity-determining region 3-specific depletion during paroxysm of nonendemic malaria infection.

Martini F, Paglia MG, Montesano C, Enders PJ, Gentile M, Pauza CD, Gioia C, Colizzi V, Narciso P, Pucillo LP, Poccia F.

Infect Immun. 2003 May;71(5):2945-9.

Supplemental Content

Loading ...
Support Center